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This work is a second step towards the systematic study of the embedding of sulfonamide antibiotics into a
synthetic high silica zeolite Y (HSZ-Y) with hydrophobic properties. In the previous paper [Braschi et al.,
Langmuir 2010, 31, 9524], the irreversible adsorption from water into HSZ-Y of three sulfonamides was
studied by enlightening the host–guest interactions and, in the case of the smallest sized sulfadiazine, the
guest–guest interactions of dimeric species inside the zeolite cage. Here the HSZ-Y was loaded with six
sulfonamides, namely: sulfanilamide, sulfapyridine, sulfathiazole, sulfadimethoxine, sulfadoxine and
sulfamerazine. With the exception of sulfanilamide, which showed scarce affinity for HSZ-Y (maximum
loading 3% zeolite dry weight), the other sulfa drugs adsorbed at ca. 28% zeolite dry weight on average,
and this is relevant for both water depollution and drug delivery issues. The low affinity of sulfanilamide
for HSZ-Y was ascribed to its high hydrophilicity (water solubility 15–40 times higher than other drugs).
The most stable tautomeric (amide or imide) form of each antibiotic adsorbed in zeolite Y was proposed
by means of IR and solid state NMR spectroscopy augmented by computational modelling. The small
dimensions and favourable stabilization energy allow the embedding of imidic and amidic dimers of
sulfathiazole and sulfapyridine, respectively, inside the zeolite cage whereas the remaining sulfa drugs
adsorbed in monomeric amidic forms.
1. Introduction
Since their discovery in the 1930s, up to now sulfonamide
antibiotics (sulfa drugs) have been used for their broad
spectrum of activities against bacterial, protozoal and fungal
infections in human therapy, livestock production and
aquaculture.1–3 Sulfonamides represent in Europe the third
most commercialized antibiotic class for veterinary applica-
tion.3 The administration of doses that are higher than needed
and the failure to respect a proper withdrawal period before
butchering can result in the occurrence of unwanted residues
in edible products.4,5 The persistence of sulfa drugs is not
limited to foodstuffs, but it is also a concern in soil
compartments, owing to the spreading of manure contami-
nated by antibiotics.
Sulfonamides are formed by an aniline ring attached by C4
to the sulphur atom of a sulfonamide moiety (–SO2–NH–). The
sulfonamide nitrogen atom can be differently substituted with
a hydrogen atom (sulfanilamide, see Table 1) or with an
aromatic heterocycle ring. In some pro-drugs, the sulfonamide
nitrogen atom forms an azo group (–NLN–) which is usually
hydrolysed in situ to sulfanilamide. The acidic nature of the
sulfonamide moiety6 makes these drugs partially anionic at
the pH values of agricultural soils and natural or artificial
water bodies. In the anionic form, sulfonamides are scarcely
adsorbed and slightly degraded in the soil system.7,8 As a
consequence of their persistence, sulfonamides can exert a
high level of bacterial resistance.9,10
Despite the need to find affordable sorbents to clean-up
water bodies polluted with sulfonamides, only a methodology
based on high silica zeolite Y (HSZ-Y) has been proposed.11–13
HSZ-Y with a 200 SiO2/Al2O3 molar ratio ensures a fast and
irreversible removal of sulfadiazine, sulfamethazine and
sulfachloropyridazine from water12 thanks to the occurrence
of multiple interactions (namely van der Waals and weak
H-bonding) between zeolite cages and sulfonamides.13 The
maximum amount of sulfonamide adsorbed by HSZ-Y is
around 20% zeolite dry weight (DW).12 This amount is high
enough to consider this material not only affordable for the
clean-up issue, but also interesting for drug delivery purposes.
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In fact, the reduction of environmental drug pollution can also
be achieved by limiting the drug amount released during in
vivo treatments. The use of matrices for drug delivery usually
allows a control of the administered drug amount by
increasing its bioavailable portion.
The nature of adsorbed sulfonamides and their arrange-
ment in inorganic matrices can influence their release, and for
this reason it is relevant to define the structure of adsorbed
species and the interactions involved with the matrix. In the
case of sulfadiazine loaded in HSZ-Y, the placement of dimeric
species inside zeolite cavities was observed owing to the small
dimension of this drug molecule in comparison with the
others investigated.13
In this study, the embedding into the HSZ-Y was evaluated
for six sulfa drugs with different molecular structures and
steric hindrances. A combined Fourier transform infrared
(FTIR) and solid state nuclear magnetic resonance (SS-NMR)
spectroscopy study, augmented with computational model-
ling, allowed us to identify the prevalent tautomer between the
amide and imide forms embedded into the HSZ-Y cage for
each sulfonamide investigated.
2. Methodologies
A. Materials
Sulfanilamide (4-aminobenzenesulfonamide, SN), sulfathia-
zole (4-amino-N-(1,3-thiazol-2-yl)benzenesulfonamide, ST), sul-
famerazine (4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfo-
namide, SMZ), sulfadimethoxine (4-amino-N-(2,6-dimethoxy-
pyrimidin-4-yl)benzenesulfonamide, SDM), and sulfadoxine (4-
amino-N-(5,6-dimethoxy-4-pyrimidinyl)benzenesulfonamide,
SDX) were purchased as analytical standards from Dr
Ehrenstorfer GmbH (Germany) with purities of 99.0%,
99.5%, 99.5%, 97.5%, and 98.0%, respectively. Sulfapyridine
(4-amino-N-pyridin-2-ylbenzenesulfonamide, SP) was supplied
by Fluka Analytical with a purity of 99%. The structure and
Table 1 Structures and physico-chemical properties of the sulfonamide antibiotics under investigation
Chemical Structure
Sulfonamides
(Acronym)
Molecular
weight g mol21 pKa
Water
Solubility g L21
Adsorption into
HSZ-Ya %
zeolite DW
Sulfanilamide (SN) 172.2 10.6b 7.50c 3
(n.d.)
Sulfathiazole (ST) 255.3 7.11d 0.47e 28
(30.2)
Sulfapyridine (SP) 249.1 8.29b 0.268c 26
(29.0)
Sulfamerazine (SMZ) 264.3 6.90d 0.202c 28
(29.8)
Sulfadimethoxine (SDM) 310.3 6.08d 0.345e 28
(29.9)
Sulfadoxine (SDX) 310.1 5.81f 0.30e 27
(28.9)
a Data obtained by HPLC analysis (in brackets data obtained by thermogravimetric analysis is reported). pKa Values are obtained from:
b ref.
14, c ref. 15, d ref. 16, e ref. 17, f ref. 18.
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physico-chemical properties of the sulfonamides are reported
in Table 1.
Y type high silica faujausite zeolite powder with a 200 SiO2/
Al2O3 ratio (hereafter named HSZ-Y), 7.0 Å 6 7.1 Å access
windows and a 12-membered ring window diameter was
purchased (code HSZ-390HUA) in its protonated form from
Tosoh Corporation (Japan). This zeolite had a total specific
surface area of ca. 850 m2 g21, most of which was related to the
presence of structural micropores (616 m2 g21) as defined
elsewhere.12
B. Adsorption trials
For each antibiotic 250 mL of 0.3 mM solution was prepared in
distilled water and added to 100 mg of HSZ-Y. The amount of
antibiotic was calculated in order to slightly exceed the
maximum adsorption capacity of HSZ-Y already determined
by us for other sulfonamides.12 According to our study the
zeolite adsorption capacity numerically equals the full
occupancy of zeolite cavities (ca. 4 6 1020 cages per 1 g
zeolite) by single antibiotic molecules. The adsorption was
conducted at room temperature (RT) in polyallomer centrifuge
tubes (Nalgene, New York, USA). Zeolite suspensions were
shaken for 2 h and then centrifuged at 20 000 g for 15 min.
Such a short contact time was chosen because it was already
reported that the adsorption of sulfa drugs by HSZ-Y takes a
few minutes.12 Finally, an aliquot of the supernatant was
withdrawn and analyzed by HPLC under chromatographic
conditions described elsewhere.12 Under these chromato-
graphic conditions, the retention times for SN, ST, SP, SMZ,
SDM, and SDX were 3.08, 3.41, 12.02, 2.71, 5.17, and 5.64 min,
respectively. All solvents were HPLC grade.
The loading of antibiotic embedded into HSZ-Y was also
confirmed by thermogravimetric analysis (TGA) carried out
using experimental conditions already described elsewhere.12
The TGA results of the sulfa drugs loaded into HSZ-Y are
reported in Table 1. The TG and derivative (DTG) profiles are
shown in Fig. 1S in the Supporting Information3.
C. Infrared spectroscopy
Fourier transform infrared (FTIR) spectra were collected on a
Thermo Electron Corporation FT Nicolet 5700 Spectrometer
with 4 cm21 resolution. Self-supporting pellets of HSZ-Y and
HSZ-Y/sulfonamide samples were obtained with a mechanical
press at ca. 7 tons cm22 and placed into an IR cell equipped
with KBr windows permanently attached to a vacuum line
(residual pressure: ¡1 6 1024 Torr; 1 Torr = 133.33 Pa),
allowing all treatments and D2O adsorption experiments to be
carried out in situ. Air-dried HSZ-Y/sulfonamide samples were
outgassed at RT for 30 min in order to remove adsorbed water
before FTIR analysis. FTIR spectra of pure sulfonamides in
CH2Cl2 of spectrophotometric grade (J. T. Baker, NJ, USA) were
performed on sulfa drugs in a standard cell for liquids
equipped with NaCl windows.
D. Solid state nuclear magnetic resonance spectroscopy
Solid state nuclear magnetic resonance (SS-NMR) spectra were
acquired on a Bruker Avance III 500 spectrometer and a wide
bore 11.7 Tesla magnet with operational frequencies for 1H
and 15N of 500.13 and 50.68 MHz, respectively. A 4 mm triple
resonance probe with MAS was employed and the samples
were packed on a Zirconia rotor and spun at a MAS rate of 15
kHz. The magnitude of the radio frequency field was 100 kHz
for 1H and the relaxation delay, d1, was between 1 and 600 s.
For the 15N{1H} CPMAS experiments, the magnetic fields of
100 and 52 kHz were used for initial excitation and
decoupling, respectively. During the CP period the 1H RF field
was ramped using 100 increments, whereas the 15N RF field
was maintained at a constant level. During the acquisition, the
protons are decoupled from the nitrogen by using a TPPM
decoupling scheme. A moderately ramped RF field was used
for spin locking, while the nitrogen RF field was matched to
obtain an optimal signal and a CP contact time of 2 ms was
used. A MAS rate of 5 kHz and a relaxation delay of 1–2 s were
employed in all the experiments. All chemical shifts are
reported using the d scale and are externally referenced to TMS
at 0 ppm.
E. Models and ab initio calculations
All calculations were performed at the density functional level
(DFT) with TURBOMOLE V619 or Gaussian03 packages.20 The
hybrid density functional B3LYP21–23 was used, along with a
Gaussian-type atomic orbital basis formed by a Hay and Wadt
basis set24–26 for the Si valence shell, and 6-31G basis set27
supported by polarization functions for all the atoms (result-
ing in the so-called 6-31G(d,p) set) for all the other elements.
Harmonic vibrational spectra were calculated at the same level
for the minimum energy conformations: to facilitate the
comparison with experimental FTIR spectra, a Gaussian
function with 1 cm21 full width at half maximum (FWHM)
was associated to each adsorption line in the simulated
spectra.
NMR isotropic chemical shieldings were computed with
larger basis sets, namely 6-311+G(d,p)28 and aug-cc-PVTZ29, at
the geometries optimized with the above-mentioned smaller
basis.
When necessary, the solvent effects on the structures and
relative energies were computed using the Conductor-like
Polarizable Continuum Model (C-PCM).30
The zeolite cage was extracted from the crystalline structure
of faujasite Y (CIF file available as Supplementary Material in
ref. 13): the material was formed by tetrahedral cavities
approximately 16 Å wide, with four large access windows,
formed by 12-membered T rings, while the cavity walls were
formed by 4- and 6-membered T rings, each window being
shared by two adjacent cavities. In the calculations a single
cavity was modeled, using outward pointing -OH to saturate
the Si valencies, so that the stoichiometry of the model cage
was Si48O72(OH)48. The tridimensional structure of the
material, along with a single cavity and the model cavity used
in the simulations are shown in Fig. 1 of ref. 13.
During the geometry optimizations, only the adsorbed sulfa
drugs were allowed to rearrange, while the zeolite atoms were
kept fixed in their crystallographic positions.
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3. Results and discussion
Six sulfonamides substituted differently at the sulfonamide
nitrogen atom (see the structures in Table 1) were chosen
among the most commercialized ones in order to better define
the influence of the heterocycle and the nature of its
substituents on their confinement in the HSZ-Y cage.
A. Adsorption of sulfa drugs in HSZ-Y
With the exception of sulfanilamide, the amount of the
remaining five sulfonamides adsorbed into zeolite was
determined by HPLC at 27% zeolite DW on average. A similar
figure (28% zeolite DW on average) was found by TG analysis
(Table 1). Thermograms are reported in the Supporting
Information (Fig. 1S, 3). The water content for this hydro-
phobic zeolite is of ca. 1% zeolite weight.13 For all antibiotics
the maximum weight loss temperatures related to product
degradation are different from pure compounds, thus suggest-
ing the embedding of sulfa drug molecules inside zeolite
cages. In addition, the loading of sulfa drugs into HSZ-Y is so
high that it cannot be explained by a simple adsorption on
external zeolite surfaces.
Making a calculation of the maximum adsorption capacity
assuming one molecule of sulfonamide per zeolite cage (4 6
1020 cage g21 zeolite DW),12 the adsorbed amount expected
was 17% zeolite DW for sulfathiazole and sulfapyridine, 18%
for sulfamerazine, and 21% for sulfadimethoxine and sulfa-
doxine. The drug amount measured in HSZ-Y upon adsorption
is higher than the maximum calculated, thus suggesting the
formation of antibiotic multilayers on the external surface of
zeolite grains and/or the formation of dimeric species inside
zeolite cavities, as already observed for sulfadiazine.13
On the contrary, the adsorption of sulfanilamide was limited
at about 3% zeolite DW. Sulfonilamide was the first
sulfonamide antibiotic to be discovered in 19321 and was
obtained by the in situ hydrolysis of azo dye Prontosil (4-[(2,4-
diaminophenyl)azo]benzenesulfonamide). The structure of
sulfonilamide is the same as other sulfonamides, except for
the presence at the sulfonamide nitrogen of a hydrogen atom
in the place of a heterocyclic aromatic ring (Table 1). The
scarce adsorption of sulfanilamide may be due to its water
solubility, which is exceedingly higher (15–40 times) than the
other sulfonamides studied here. Further investigations on the
HSZ-Y/sulfanilamide sample were not performed owing to the
low affinity of sulfanilamide for hydrophobic HSZ-Y.
The nature of the interactions between sulfa drugs and HSZ-
Y was investigated by FTIR, SS-NMR and DFT ab initio
calculations.
B. Computational modelling
The geometries of the isolated sulfa drugs (except sulfanila-
mide, vide supra) were optimized in vacuum and the harmonic
vibrational frequencies were computed at the DFT level to
assist the interpretation of FTIR spectra, as discussed below.
Different tautomers are possible for such species: we
considered the amidic structures, containing the sulfonamide
group (–SO2–NH–), along with the imidic forms (–SO2–NL)
where the hydrogen atom is bound to a heterocycle nitrogen.
The optimized structures of amidic and imidic tautomers of all
considered sulfa drugs are shown in Fig. 1: note that the
imidic structures are stabilized by an intramolecular H bond
resulting in a 6 membered ring which connects the heterocycle
NH to one of the sulfone oxygen atoms. The tautomeric forms
involving protonated sulfone oxygen atoms (–SO(OH)LN–)
were already excluded in a previous work on analogous sulfa
drugs, due to their much higher formation energies and the
disagreement between calculated and experimental vibrational
spectra.13
It is known that in the solid state sulfathiazole is more
stable in the imidic tautomer, while the amidic form is found
in polymorphs I–IV of solid sulfapyridine.31 To investigate the
tautomer stability of the selected sulfonamides, the optimized
energies in vacuum, in dichloromethane and in water were
compared using the Gaussian03 package and the C-PCM
continuum model for the solvent, with the results reported in
Table 2. The calculations indicate that both in vacuum and in
solution, the imidic form is favoured only for sulfathiazole,
whereas the other sulfa drugs prefer the amidic structure.
Dimers of the same species were also optimized in vacuum,
and the corresponding harmonic frequencies computed: in all
amidic dimers, two hydrogen bonds establish between the
sulfonamide groups and the partner’s heterocycle nitrogen
atoms. Imidic dimers may even form as discussed below. As
suggested by the discussion on the energies calculated for
tautomers of isolated sulfa drugs, the dimers also present two
distinct minima, with the hydrogen atoms involved in the
intermolecular H-bonds closer to sulfonamide or heterocycle
nitrogen atoms (dimers formed from amidic or imidic
monomers, respectively).
The dimer formation energies are reported in Table 2,
referring to the corresponding isolated isomers: note that for
sulfathiazole the dimerization energies refer to two monomers
in the imide form, while for all the other drugs they refer to
amidic monomers. The structure of the most stable sulfa drug
dimers are shown in Fig. 1.
As expected, in vacuum the computed formation energies
are favourable for all the sulfa drug dimers with respect to the
monomers (Table 2). To evaluate the plausibility of dimer
formation inside the zeolite cage, sulfathiazole, sulfapyridine,
and sulfamerazine dimers were reoptimized in the model cage
described above (Fig. 2).
The three dimers remain bound inside the cage, but
sulfamerazine is strongly distorted, as indicated by the N–
H…N angles (passing from 173u, 174u in vacuum to 154u and
163u in the cage), whereas sulfathiazole and sulfapyridine
dimers maintain the planarity of the H-bonded moieties (all
the H-bond angles in the cage being in the range 171–175u). In
general, the optimized structures confirm that sulfathiazole
and sulfapyridine dimers are less sterically hindered than
sulfamerazine, as is also the case for the other sulfa drugs,
bearing even bulkier side groups (see Table 1).
As said above, the harmonic frequencies were computed for
all the optimized structures, amidic and imidic monomers and
dimers, to have a complete set of theoretical spectra to be
compared with the experimental data.
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Fig. 1 DFT optimized structure of amidic and cyclic imidic monomers and the most stable dimers of sulfa drugs in vacuum. The imidic form is reported for the
sulfathiazole dimer whereas the amidic form is for the other dimers.
Table 2 Computed relative energies (kcal mol21) of monomeric and dimeric sulfonamide tautomers. For all the drugs, the energies refer to the most stable monomer
Amide monomer Imide monomer Amide dimer Imide dimer
Sulfa drug Medium
Sulfathiazole vacuum 3.39 0.00 215.44 217.07
CH2Cl2 3.49 0.00
water 3.48 0.00
Sulfapyridine vacuum 0.00 2.18 217.94 214.20
CH2Cl2 0.00 1.38
water 0.00 1.03
Sulfamerazine vacuum 0.00 6.41 214.04
CH2Cl2 0.00 3.80
water 0.00 3.20
Sulfadimethoxine vacuum 0.00 2.40 213.44
CH2Cl2 0.00 3.23
water 0.00 3.18
Sulfadoxine vacuum 0.00 1.95 211.92
CH2Cl2 0.00 0.84
water 0.00 0.25
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RSC Advances Paper
C. Experimental and calculated FT-IR spectra
Calculated bands (FWHM of 1 cm21) for the amidic tautomers
and experimental spectra are reported in Fig. 3.
The computed harmonic frequencies are systematically
overestimated, but it can safely be assumed that the spectra
pattern is reproduced accurately enough to allow the inter-
pretation, especially when analogous molecules can be
compared as in the present case. The visual comparison is
helped by downshifting the theoretical frequencies in order to
make the first peak for sulfadoxine coincide with the
corresponding experimental absorption, and this leads to a
shift of 170 and 75 cm21 in the high (Fig. 3A) and in the low
frequency region (Fig. 3B), respectively. The main features of
the experimental spectra are well reproduced by the calcula-
tions, especially in the high wavenumber region where aniline
NH2 and sulfonamide NH stretching vibrations absorb. The
most important vibrational frequencies are listed in Table 3
for the five sulfonamides, with the assignments obtained by
the comparison of theoretical and experimental results.
For all investigated sulfa drugs, the experimental NH2
asymmetric (nasym) and symmetric (nsym) stretching vibrations
in CH2Cl2 are at very similar positions (in the range 3502–3499
and 3406–3402 cm21, respectively), clearly indicating that
these vibrational modes are uncoupled from the others arising
from the rest of the sulfonamide structure. The corresponding
harmonic vibrations in the calculated spectra are at 3676–3668
and 3574–3566 cm21, respectively. These modes are found at
positions similar to those reported in the literature for other
sulfa drugs.13
The stretching frequency of the sulfonamide NH group
significantly differs among the five antibiotics, falling in the
range 3375–3307 cm21 and following the order: sulfamerazine
. sulfadoxine ¢ sulfapyridine ¢ sulfadimethoxine &
sulfathiazole. This trend, conversely to what has been reported
for other sulfa drugs,13 does not follow the acidic character of
the sulfonamide group of the compounds here investigated
(pKa, Table 1). Experimentally, sulfathiazole (pKa 7.11) pre-
sents the lowest amide NH stretching frequency (3307 cm21)
whereas sulfamerazine (pKa 6.90) shows the highest value at
3375 cm21. The computed harmonic frequencies do not follow
the acidity of the antibiotics as well, and the trend roughly
resembles what was experimentally found: NH stretching at
the lowest wavenumbers (3525 cm21) for sulfathiazole and at
the highest frequency (3598 cm21) for sulfamerazine.
The discrepancy between acidic constants and sulfonamidic
NH stretching frequencies can be explained considering that:
i) the pKa values were determined in a polar solvent like water,
whereas the IR spectra were collected in a nonpolar solvent
like CH2Cl2; ii) the sulfonamide NH vibration depends on the
molecular and electronic structure of the molecule as a whole,
whereas the pKa is influenced by the solvating effects of water
on both neutral and anionic forms of the sulfa drug.
As far as the intensity of the NH stretching absorption is
concerned, the sulfathiazole band is significantly the least
pronounced among the five sulfonamides. This feature
suggests that the occurrence of both the amidic and imidic
monomers for sulfathiazole (see calculated NH stretching at
3525 and 3473 cm21, Fig. 4A, curves c and d, respectively) are
limited and that the dimeric species should be present as
indicated by the experimental broad band in the region 3200–
2500 cm21 (see below, Fig. 4–6, for a detailed assignment of
this band). On the contrary, the higher NH stretching intensity
of the other sulfa drugs strongly suggests that sulfapyridine,
Fig. 2 DFT optimized structure of the most stable tautomers for sulfathiazole, sulfapyridine, and sulfamerazine dimers inside the zeolite Y model cage.
Fig. 3 Infrared spectra of sulfathiazole (ST), sulfapyridine (SP), sulfamerazine
(SMZ), sulfadimethoxine (SDM), and sulfadoxine (SDX) in CH2Cl2 (blue line) and
calculated amidic tautomers in vacuo (red line). The IR spectrum of water
clusters in CH2Cl2 is also reported (black dotted line).
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sulfamerazine, sulfamethazine, and sulfadoxine are present in
amidic form (Fig. 3A).
The experimental spectra of sulfonamides in CH2Cl2 show
complex bands in the 1640–1500 cm21 region (Fig. 3B), where
vibrations of NH2 bending along with phenyl and aromatic
heterocycle stretchings, which are often coupled with each
other, occur. For this reason a detailed description of specific
contributions is difficult, though some absorptions are clearly
assignable. As expected, the amino in-plane bending mode
(dNH2) for the five sulfa drugs is found at a very similar
frequency in the 1626–1620 cm21 range and is well reproduced
by the computational model (1697–1694 cm21). Bands at
1599–1595 cm21 are assigned to phenyl quadrant stretching
coupled to NH2 bending (the corresponding computed spectra
show bands in the range 1659–1657 cm21). This mode is well
defined in all sulfonamide spectra, with the exception of
sulfamerazine and sulfadoxine where it is overlapped to an
intense contribution at 1606 cm21, due to water (see dotted
curve in Fig. 3B) present in these sulfa drugs formulations.
As far as the heterocycle vibrations are concerned, two main
vibrational modes of the heterocyclic ring, due to the C–C and
the C–N bonds stretchings, are predicted by the DFT
calculation and some of them are found to be coupled with
the sulfonamide NH bending (see Table 3 for details). Another
vibrational mode that does not change significantly among the
five sulfa drugs is the phenyl in-plane bending at 1504–1502
cm21 in the experimental spectra and in the 1550–1549 cm21
range in the calculated ones.
The experimental spectrum for sulfathiazole significantly
differs from that of the calculated spectrum in the amidic
form: only for this drug a strong experimental absorption at
1541 cm21 is present. In addition, specific vibrations for the
sulfathiazole heterocycle, coupled with NH2 bending, calcu-
lated at 1571 and 1520 cm21, are not evident in the
experimental spectrum (only weak and broad bands are found
in the 1480–1450 cm21 range), therefore strengthening the
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Fig. 4 Experimental infrared spectra of sulfathiazole in CH2Cl2 (curve a) and
adsorbed into zeolite HSZ-Y (curve e). The experimental spectra of water in
CH2Cl2 (curve b) and bare HSZ-Y (curve f) are also reported. The calculated
spectra of amide and imide monomers (curves c and d, respectively) and amide
and imide dimers (curves g and h, respectively) are reported for comparison.
Asterisk indicates unreliable band due to solvent subtraction.
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hypothesis that the sulfathiazole amidic form poorly con-
tributes to the experimental features.
In Fig. 4, the computed spectra of the amidic and imidic
monomers and dimers of sulfathiazole in vacuum are
compared to the experimental spectrum of sulfathiazole in
CH2Cl2, especially enlightening the region at 1650–1500 cm
21.
The computed spectrum of imidic tautomer (curve d) shows
an intense band at 1646 cm21 due to an imide NH bending
mode, which can be observed in the experimental spectrum
(curve a) at 1578 cm21. The strong absorption at 1541 cm21
(curve a) is absent in both the computed amidic and imidic
monomer spectra (curves c and d, respectively). For an
assignment of this contribution, a study of the spectroscopic
features of the dimeric species is necessary. Computed spectra
of amidic and imidic dimers are reported in Fig. 4D (curves g
and h): only in the case of the imidic dimer two strong
absorptions are calculated at 1636 and 1614 cm21 (curve h)
due to two modes of NH bending coupled to ring modes.
These modes are clearly identified in the experimental
spectrum at 1568 and 1541 cm21, thus indicating that the
imide dimer is the most abundant sulfathiazole species in
CH2Cl2. The formation of this species in a very diluted
nonpolar solvent, such as dichloromethane, is not surprising
in that, according to the stabilization energy computed in
vacuum (Table 2), dimers of sulfathiazole in the imidic form
are the most stable.
All these results lead to the evidence of the occurrence of a
consistent contribution of the imidic dimer species for
sulfathiazole in CH2Cl2, whereas for the other sulfonamides
investigated the more stable amidic form is identified.
D. Sulfonamides adsorbed in HSZ-Y
As far as the adsorption of sulfonamides into zeolite is
concerned, it is interesting to note that the position of the NH2
stretching bands (3500–3487 cm21 and 3389–3411 cm21) is
almost unchanged for the molecules embedded within the
zeolite cages (Fig. 5A, Table 3). However, each band is split into
a number of overlapping components. This feature is
characteristic of molecules experiencing slightly different
environments, either in the cage or on the external surfaces
of the zeolite crystallites.
The sulfonamide NH stretching of sulfamerazine, sulfadi-
methoxine and sulfadoxine is only weakly perturbed upon
adsorption into zeolite: this band slightly moves to higher
frequencies overlapping the band of symmetrical NH2 stretch-
ing, and for this reason it is difficult to define a precise
position. These small variations are due to very weak
interactions with oxygen atoms of the cage wall. On the
contrary, the NH stretching of sulfathiazole and sulfapyridine
in the adsorbed phase moves to frequencies ranging between
3200–2700 cm21 (also where CH stretching vibrations of
phenyl and heterocyclic rings absorb), indicating the forma-
tion of H-bonds.
The position of the H-bonded sulfonamide NH band cannot
be measured with precision because it falls in a region where
Fermi resonance interactions with overtones and/or combina-
tion bands of the sulfa drugs occur, and this leads to several
maxima overlapped with the broad NH…N absorption. A
similar broad band has been found in a recent study in
sulfadiazine sulfonamide adsorbed in the same HSZ-Y used in
this study.13 In adsorbed sulfadiazine, a NH stretching
downward shift of about 250 cm21 was attributed to the
formation of dimeric species inside the zeolite cage where the
sulfonamide group is H-bonded to the heterocycle nitrogen
(NH…N) of another sulfadiazine molecule. H-bonded dimers
can also form in the case of sulfathiazole and sulfapyridine
Fig. 5 Infrared spectra of sulfathiazole (ST), sulfapyridine (SP), sulfamerazine
(SMR), sulfadimethoxine (SDM), and sulfadoxine (SDX) adsorbed into HSZ-Y
(black lines a–e). The spectra of sulfonamides in CH2Cl2 (blue lines a9–e9) are
reported for comparison. The spectrum of pure HSZ-Y is shown by the dotted
line. The highlighted gray region in the spectra in CH2Cl2 shows some artefacts
due to the solvent subtraction.
Fig. 6 Infrared spectra of sulfathiazole (ST) and sulfapyridine (SP) adsorbed into
HSZ-Y zeolite before (black curves a and c) and after treatment with D2O (green
curves b and d).
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because of the favourable position of their heterocycle
nitrogen atoms described above in the computational model-
ing.
In this study the presence of a large band for H-bonded NH
stretching in the 3200–2700 cm21 range was confirmed by
deuteration of sulfathiazole and sulfapyridine (Fig. 6).
Upon deuteration the NH2 and NH stretching absorptions
are downward shifted in the 2800–2000 cm21 range, except the
CH stretching vibrations of the phenyl and heterocyclic rings,
which become more clearly visible in the 3200–3000 cm21
range. It is evident that the deuterated spectra (curves b and d)
are simplified especially in the 2400–2050 cm21 region where
ND…N species absorb, and this is because the Fermi
resonance effects are strongly depleted. The position of the
maxima is more clearly determined at around 2300 and 2250
cm21, respectively, for sulfathiazole and sulfapyridine. We can
thus safely assume that the position of the NH…N bands
(curves a and c) follows the same order, being at higher
wavenumbers for sulfathiazole than sulfapyridine. This experi-
ment definitely confirms that sulfathiazole and sulfapyridine
dimers are formed in the HSZ-Y cage upon adsorption.
As far as the vibrational modes in the 1700–1500 cm21
region are concerned (Fig. 5B), only small changes are evident
by comparing sulfonamides adsorbed into the zeolite and in
CH2Cl2 solution.
In the 1500–1400 cm21 spectral region, a noticeable
difference in the spectrum of sulfamerazine (SMZ) in the
adsorbed phase is the presence of a broad and intense band at
1441 cm21. In this region the computed spectrum shows an
intense vibration at 1488 cm21 due to the heterocycle carbon-
amide nitrogen stretching. The reason why this band is more
evident in the spectrum of the adsorbed sulfamerazine than in
CH2Cl2 is not clear, however, it is reasonable to assume that
the intensity of this mode is related to the interaction of the
heterocycle with the cage wall. The stretching of the C–N bond
connecting the heterocycle to the sulfonamide group is found
at 1443 and 1450 cm21 in the case of sulfadimethoxine and
sulfadoxine, respectively, adsorbed into zeolite. Likely, the
heterocycle of these drugs experiences similar environments
upon adsorption. The mode at 1441–1450 cm21 is not active in
sulfapyridine adsorbed into zeolite in the dimeric form
because of the NH…N intermolecular hydrogen bonding.
The case of sulfathiazole needs to be specifically discussed
in that this is the only sulfa drug present in imidic forms
(monomer and dimer) in CH2Cl2 solution. Upon adsorption,
the sulfathiazole spectrum in the low frequency region
(Fig. 5B) is similar to that in CH2Cl2 and the absorptions at
1565 and 1537 cm21, assigned to two NH bending modes of
imide dimers are clearly detected. This effect is more clearly
presented in Fig. 4B and 4D, where the experimental spectra
(curves a and e for sulfathiazole in CH2Cl2 and adsorbed into
HSZ-Y, respectively) are compared to the calculated monomers
and dimers in both amidic and imidic form. Two asymmetric
(3648 and 3644 cm21) and two symmetric stretching modes
(3546 and 3543 cm21) computed for the NH2 of the amidic
sulfathiazole dimer (curve g) are found, whereas for the imidic
dimers (curve h) they are calculated at 3647, 3644, 3545, and
3543, respectively. As far as the NH stretching modes of the
dimer are concerned, the asymmetric and symmetric NH
absorptions were calculated at 3119 and 3075 cm21 (weak) and
at 3184 and 3130 cm21 (very weak) for the amidic and imidic
tautomer, respectively. As discussed above, this region cannot
be used to distinguish one dimer tautomer from the other
because of the very similar corresponding frequencies.
It is worth recalling, the calculated spectrum of the imidic
dimer (Fig. 4D, curve h) shows two strong bands at 1636 and
1614 cm21 due to the two modes of imidic NH bending, which
definitely explains the presence of the strong absorption at
1568 and 1537 cm21 in the experimental spectrum (curve e) of
sulfathiazole adsorbed into HSZ-Y.
E. Solid state NMR spectroscopy
A SS-NMR study was used to support the IR findings on the
nature of the sulfa drug tautomers in the adsorbed phase. In
addition, theoretical chemical shieldings were computed for
all the drugs, both monomers and dimers: the full list of 1H,
13C and 15N chemical shifts (referred to NH3 and TMS at the
same level) is available as Supplementary Material.3 The most
relevant computational results are discussed below.
Fig. 7 shows the 1H MAS NMR spectra recorded at a
moderate MAS rate (15 kHz) on different sulfa drugs adsorbed
on zeolite. For the purpose of comparison, the 1H MAS NMR
spectra of solid crystalline sulfa drugs are also presented.
Very broad peaks of the crystalline sulfa drugs are due to the
non-averaging of 1H21H homonuclear dipolar couplings,
nevertheless, a moderate MAS rate is sufficient to resolve the
highly polarized H-bonded proton chemical shifts.32 While in
sulfathiazole and sulfapyridine the chemical shifts due to
H-bonded protons are visible as weak and broad signals in the
Fig. 7 1H NMR spectra of sulfathiazole (ST), sulfapyridine (SP), sulfamerazine
(SMZ), sulfadimethoxine (SDM), and sulfadoxine (SDX) adsorbed into HSZ-Y
zeolite. Spectra of pure antibiotics are reported for comparison.
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range 14.0213.0 ppm, a well resolved peak at 12.5 ppm is seen
in sulfamerazine. Such low-field proton chemical shifts
indicate strong H-bonding in the crystalline state and are
absent in pure sulfadimethoxine and sulfadoxine.
In the adsorbed samples, the 1H MAS spectra are dominated
by aliphatic and aromatic proton peaks in sulfamerazine (HSZ-
Y/SMZ), sulfadimethoxine (HSZ-Y/SDM) and sulfadoxine (HSZ-
Y/SDX), whereas only aromatic peaks in sulfathiazole (HSZ-Y/
ST) and sulfapyridine (HSZ-Y/SP) were detected. Clearly, the
existence of H-bonded proton sites are only visible in two
adsorbed systems, namely, HSZ-Y/ST (12.2, 13.3 ppm) and
HSZ-Y/SP (11.0 ppm). Noncovalent interactions (mainly
H-bonding, van der Waals and hydrophilic/hydrophobic
interactions) play a fundamental role in the adsorption of
sulfa drugs in HSZ-Y due to their selectivity, specificity,
directionality and strength.13 All the sulfa drugs under study
are capable of forming intermolecular hydrogen bonding of
the nature N–H…O and N–H…N. However, only HSZ-Y/ST and
HSZ-Y/SP show strong H-bonding as evident from the low-field
peaks in full agreement with the formation of dimers shown
by the computational modelling and IR combined study. The
computed chemical shifts (see Supplementary Material 3)
agree with this picture: in all the dimers the protons involved
in the intermolecular H-bond are markedly shifted downfield
with respect to the monomers, moving e. g. from 10.4 to 14.2
ppm for ST, and from 6.2 to 12.7 for SP.
As discussed for HSZ-Y/ST, two low-field peaks (12.2, 13.3
ppm) corresponding to the two distinct H-bonded protons can
be observed, however, in HSZ-Y/SP, only one broad low-field
peak (11.0 ppm) is found. It is further interesting to note that,
low-field peaks were observed for pure sulfatiazole (ST: 14.0
ppm) and sulfapyridine (SP: 13.0 ppm) with a marked increase
in the isotropic chemical shifts compared to loaded zeolite
systems. Such pronounced differences in the chemical shifts
indicate a more disordered packing arrangement in adsorbed
systems as compared to pure crystalline drugs. In general,
three dimensionally extending intermolecular and intramole-
cular H-bonding links between dimers forming chains,
ladders, layers, etc. are observed in pure crystalline sulfa
drugs,33 however, such extended structure formation is
impossible in the adsorbed systems due to the space
restriction of cages. The difference in the H-bonded reso-
nances in HSZ-Y/ST and HSZ-Y/SP could be explained in terms
of the interplay between the changing electronic and steric
effects of the thiazole/pyridine ring.
Focusing on the remaining adsorbed systems, the absence
of dimer formation in HSZ-H/SMZ, HSZ-Y/SDM and HSZ-Y/
SDX can be rationalized in terms of the increased steric effects
on the heterocyclic ring due to the methyl/methoxyl substitu-
tion. With increasing heterocycle substitution, the steric bulk
of the methyl/methoxyl groups hinders the approach of the
monomers to form intermolecular H-bonded dimer links.
The molecular nature of the sulfa drugs in HSZ-Y was
determined by 15N{1H} CPMAS NMR experiments in 15N
natural abundance. Fig. 8 shows the 15N CPMAS spectra of
sulfa drugs adsorbed into HSZ-Y which are recorded at RT with
a short contact time (2 ms) and a moderate MAS rate (5 kHz).
All the spectra show 2 resonances due to the NH2 and NH at
around 62 ppm and 140 ppm (reference solid: glycine, 32.9
ppm), respectively, except for the HSZ-Y/ST. In contrast to the
expectations of a single band for NH in HSZ-Y/ST, two peaks at
162 and 190 ppm were observed. All the resonances are
expected from the protonated 15N as a short cross polarization
contact time was used in all experiments. The dramatic low
field shift and the existence of two different resonances for the
NH group can be due to different geometries around this
nitrogen which are fixed by the molecular environment. The
absence of a unique intrinsic chemical shift for the same NH
group was assumed to be due to the proton disorder at 15N. In
other words, either two different NH groups, which inter-
convert rapidly, or more tautomers are expected.
The comparison with theoretical chemical shifts (see
Supplementary Material 3) can help to analyze the results:
note that the calculations refer to isolated drugs (either
monomers or dimers) and thus a systematic error with respect
to the adsorbed samples is expected, nonetheless the shape of
the spectra can be fruitfully compared. The computed
chemical shifts for NH2 occur at similar values for all the
monomer systems, and little variations are found when
passing to dimers. The lower field resonances are attributed
to the heterocycle NH group in imidic ST and to the SO2–NH
moiety in the other drugs: notably, ST is the only system which
exhibits a marked downfield shift passing from monomer to
dimer (163 to 184 ppm). One can see that the experimental
NMR spectra are not compatible with the presence of
monomer ST (which would be expected to show a lower
chemical shift than all the other systems), while they
qualitatively agree with the presence of dimer ST (for which
a higher chemical shift is computed). 15N spectra provide little
information about dimer SP species, since their resonance is
computed in the same range as for monomer drugs: on the
other hand, the 1H spectra commented on above clearly show
the presence of H-bonding also in this system, unlike SMZ,
SDM and SDX.
Fig. 8 15N{1H}CPMAS NMR spectra of HSZ-Y zeolites adsorbed sulfathiazole
(HSZ-Y/ST), sulfapyridine (HSZ-Y/SP), sulfamerazine (HSZ-Y/SMZ), sulfadi-
methoxine (HSZ-Y/SDM) and sulfadoxine (HSZ-Y/SDX).
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4. Conclusions
In the present study the occurrence of monomeric and dimeric
species of sulfonamide antibiotics inside high silica zeolite Y
(HSZ-Y) cage was studied by loading sulfa drugs of different
dimensions and nature of substituents from water solutions.
The adsorption of five out of the six sulfa drugs by HSZ-Y is
remarkable, attesting at around 28% zeolite DW on average,
being interesting for both the purpose of water depollution
and drug delivery issues. The drug solubility negatively
affected the adsorption as shown by the scarce loading of
highly soluble sulfanilamide.
The host–guest and guest–guest interactions of the zeolite-
drug and drug–drug complexes have been studied by FT-IR, SS-
NMR and computational modeling. Sulfonamides of the
lowest dimensions (sulfathiazole and sulfapyridine) were able
to form dimers inside the zeolite cage, whereas those of the
biggest size (sulfamerazine, sulfadimethoxine, and sulfadox-
ine) were embedded as single molecules.
The ability of sulfonamides to exist under amidic or imidic
tautomeric forms has been known for many decades, but the
involved studies dealt with crystal structures. In this study, the
most stable tautomer of sulfonamides in dichloromethane
and embedded into a zeolite cage was defined and, for the first
time, 15N{1H}CPMAS NMR spectroscopy was successfully used
to confirm the most stable tautomer of the sulfa drugs
embedded into the inorganic matrix. Due to the favourable
stabilization energy, both monomers and dimers of imide
sulfathiazole and amidic sulfapyridine were embedded inside
a zeolite cage, whereas the other sulfa drugs were adsorbed as
single molecules in amidic form.
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